List of cancer drugs
People with cancer may have conditions caused by the cancer or its treatment. Find drugs approved for some of these cancer-related conditions.
Types of Cancer Drugs[edit]
Cancer treatments have significantly diversified with advances in medical science, leading to the development of various drugs that target cancer cells with precision. These drugs are classified based on their mode of action, each playing a pivotal role in oncology. This article explores the primary categories of cancer drugs, illustrating each with examples to provide insight into their function and application in cancer therapy.
Chemotherapy[edit]
Chemotherapy encompasses a broad range of drugs that kill rapidly dividing cells, a hallmark of cancerous tissues. Subcategories include:
- Alkylating agents: Cyclophosphamide and Ifosfamide
- Antimetabolites: Methotrexate and 5-Fluorouracil (5-FU)
- Anti-tumor antibiotics: Doxorubicin and Bleomycin
- Topoisomerase inhibitors: Irinotecan and Etoposide
- Mitotic inhibitors: Paclitaxel and Vincristine
These drugs can be administered for various purposes, including cure, tumor size reduction, symptom management, and in combination with other treatments like surgery or radiation therapy.
Targeted Therapy[edit]
Targeted therapy zeroes in on specific molecular targets associated with cancer, offering a more refined approach to treatment. Examples include:
- Tyrosine kinase inhibitors: Imatinib (Gleevec) and Erlotinib (Tarceva)
- Monoclonal antibodies: Trastuzumab (Herceptin) for HER2-positive breast cancer and Rituximab (Rituxan) for B-cell non-Hodgkin's lymphoma
Hormonal Therapy[edit]
Hormonal therapy is crucial for cancers that grow in response to hormones, such as some breast and prostate cancers. It includes:
- Selective estrogen receptor modulators (SERMs): Tamoxifen
- Aromatase inhibitors: Anastrozole (Arimidex) and Letrozole (Femara)
Immunotherapy[edit]
Immunotherapy enhances the immune system's ability to combat cancer, with treatments like:
- Checkpoint inhibitors: Pembrolizumab (Keytruda) and Nivolumab (Opdivo)
- CAR T-cell therapy: Tisagenlecleucel (Kymriah) for certain acute lymphoblastic leukemias
Radiopharmaceuticals[edit]
Radiopharmaceuticals deliver radiation directly to cancer cells, sparing healthy tissues. Notable examples are:
- Iodine-131 for thyroid cancer
- Radium-223 (Xofigo) for bone metastases from prostate cancer
Angiogenesis Inhibitors[edit]
Angiogenesis inhibitors prevent tumors from developing new blood vessels, essential for their growth. A key drug in this category is Bevacizumab (Avastin).
Cancer Vaccines[edit]
Cancer vaccines aim to provoke an immune response against cancer-specific antigens. Therapeutic vaccines like Sipuleucel-T (Provenge) for prostate cancer are under continuous research for efficacy against various cancers.
Comprehensive list of antineoplastic agents (cancer drugs)[edit]
- 2-Methoxyestradiol
- 20α-Dihydroprogesterone
- 3,3'-Diindolylmethane
- 4'-Hydroxynorendoxifen
- 4-Aminosalicylic acid
- 4-Androstene-3,6,17-trione
- 4-Deoxypyridoxine
- 4-Hydroxycyclophosphamide
- 4-Hydroxytestosterone
- 5N-Bicalutamide
- 5α-Dihydronorethisterone
- 6-Diazo-5-oxo-L-norleucine
- 7+3 (chemotherapy)
- 8-Azaguanine
- ABT-510
- ABTL0812
- ABVD
- ADE (chemotherapy)
- ADH-1
- AI-10-49
- ALK inhibitor
- AM-251 (drug)
- AMG 319
- AOH1996
- ATC code L01
- Abagovomab
- Abexinostat
- Abiraterone acetate
- Abituzumab
- Abrocitinib
- Acacetin
- Acadesine
- Acalabrutinib
- Acefluranol
- Aceglatone
- Aclarubicin
- Acolbifene
- Acridine carboxamide
- Actinium-225
- Acutissimin A
- Adagrasib
- Adavosertib
- Adecatumumab
- Adegramotide
- Adjuvant therapy
- Adozelesin
- Afatinib
- Afimoxifene
- Aflibercept
- Alacizumab pegol
- Alanosine
- Alatrofloxacin
- Aldoxorubicin
- Alectinib
- Alemtuzumab
- Alestramustine
- Alitretinoin
- Alkyl-lysophospholipids
- Allovectin-7
- Allylestrenol
- Altretamine
- Alvocidib
- Amarogentin
- Amatuximab
- Amifloxacin
- Amifostine
- Amikhelline
- Aminoglutethimide
- Aminolevulinic acid
- Aminopterin
- Amivantamab
- Amonafide
- Amphinex
- Amrubicin
- Amsacrine
- Anabolic steroid
- Anagrelide
- Anastrozole
- Anatumomab mafenatox
- Androgen receptor degrader
- Androstenediol diacetate
- Anecortave acetate
- Angiogenesis inhibitor
- Angiogenesis inhibitors
- Angiokinase inhibitors
- Angiostatin
- Angiozyme
- Annamycin
- Anthracycline
- Anthracyclines
- Anthramycin
- Anti-CD22 immunotoxin
- Antiandrogen
- Antibody–drug conjugate
- Anticarcinogen
- Antiestrogen
- Antifolate
- Antifolates
- Antimetabolite
- Antimetabolites
- Apalutamide
- Apatinib
- Apaziquone
- Aphidicolin
- Apigenin
- Aromatase inhibitor
- Aromatase inhibitors
- Arsenic trioxide
- Artemisinin
- Asciminib
- Ascrinvacumab
- Asparaginase
- Asunercept
- Atamestane
- Atezolizumab
- Atiprimod
- Atrasentan
- Atrimustine
- Autogene cevumeran
- Avapritinib
- Avelumab
- Axicabtagene ciloleucel
- Axitinib
- Azacitidine
- Azaserine
- Azathioprine
- BEACOPP
- BI 811283
- BMS-641988
- BOLD-100
- Bafetinib
- Baicalein
- Balofloxacin
- Baricitinib
- Bavituximab
- Bazedoxifene
- Bectumomab
- Belantamab mafodotin
- Beloranib
- Belotecan
- Bemcentinib
- Bempegaldesleukin
- Bendamustine
- Benzilylcholine mustard
- Berberine
- Bergapten
- Besifloxacin
- Bevacizumab
- Bexarotene
- Bicalutamide
- Bifonazole
- Biochanin A
- Biosynthesis of doxorubicin
- Birabresib
- Biricodar
- Bis(2-chloroethyl)sulfide
- Bivatuzumab mertansine
- Bleomycin
- Blinatumomab
- Blister agent
- Blister agents
- Bohemic acid
- Bortezomib
- Bosutinib
- Brentuximab vedotin
- Brigatinib
- Brilanestrant
- Brivanib alaninate
- Bromoketoprogesterone
- Bropirimine
- Brostallicin
- Bryostatin
- Buparlisib
- Buserelin
- Busulfan
- Buthionine sulfoximine
- C-1027
- CAPOX
- CBV (chemotherapy)
- CEPP
- CHOP (chemotherapy)
- CMF (chemotherapy)
- COPP (chemotherapy)
- CP-944629
- CRLX101
- CYP17A1 inhibitor
- Cabazitaxel
- Cabozantinib
- Cadonilimab
- Calaspargase pegol
- Camidanlumab tesirine
- Camptothecin
- Canakinumab
- Cancer immunotherapy
- Canertinib
- Cantharidin
- Cantuzumab mertansine
- Cantuzumab ravtansine
- Capecitabine
- Capmatinib
- Carboplatin
- Carboquone
- Carboxycyclophosphamide
- Carfilzomib
- Carmofur
- Carmustine
- Carubicin
- Catumaxomab
- Cediranib
- Celecoxib
- Cemiplimab
- Cerdulatinib
- Ceritinib
- Cetuximab
- Chemically linked Fab
- Chemoimmunotherapy
- Chemoprotective agent
- Chemosensitizer
- Chemotherapy
- Chemotherapy regimen
- Chemotherapy regimens
- Chlorambucil
- Chlormadinone acetate
- Chlormethine
- Chlornaltrexamine
- Chlornaphazine
- Chloroethylclonidine
- Chlorotoxin
- Chlorotrianisene
- Chloroxymorphamine
- Chlorozotocin
- Chrysin
- Cilengitide
- Ciltacabtagene autoleucel
- Ciprofloxacin
- Cirmtuzumab
- Cisplatin
- Citatuzumab bogatox
- Cixutumumab
- Cladribine
- Clevegen
- Clinafloxacin
- Clofarabine
- Clostridium novyi-NT
- Clotrimazole
- Cobimetinib
- Cofetuzumab pelidotin
- Combretastatin A-4
- Conbercept
- Conjugated estrogens
- Conjugated linoleic acid
- Copanlisib
- Cortifen
- Coumestrol
- Crenolanib
- Crimidine
- Crizotinib
- Cryptolepine
- Custirsen
- Cyclophosphamide
- Cyproterone acetate
- Cytarabine
- Cytestrol acetate
- Cytoskeletal drugs
- DAT (chemotherapy)
- DHA-paclitaxel
- DHAP (chemotherapy)
- DSP-4
- DT-PACE
- Dacarbazine
- Dacetuzumab
- Dacomitinib
- Dactinomycin
- Dactolisib
- Damnacanthal
- Danofloxacin
- Daratumumab
- Darinaparsin
- Darolutamide
- Dasatinib
- Daunorubicin
- Daunorubicin/cytarabine
- Decitabine
- Delafloxacin
- Delgocitinib
- Demcizumab
- Denifanstat
- Denileukin diftitox
- Denintuzumab mafodotin
- Depatuxizumab mafodotin
- Deruxtecan
- Detumomab
- Deucravacitinib
- Deuruxolitinib
- Devimistat
- Dexrazoxane
- Dibrospidium chloride
- Dichloroacetic acid
- Dicycloplatin
- Diethylstilbestrol
- Diethylstilbestrol disulfate
- Diflomotecan
- Difloxacin
- Dihydrofluoxymesterone
- Dinaciclib
- Discodermolide
- Docetaxel
- Dose-dense chemotherapy
- Dostarlimab
- Doxifluridine
- Doxorubicin
- Droloxifene
- Dronabinol
- Drostanolone propionate
- Duligotuzumab
- Duocarmycin
- Durvalumab
- Dusigitumab
- Dutasteride
- Duvelisib
- EM-5854
- EPI-7386
- EPOCH (chemotherapy)
- ERX-11
- ESHAP
- Econazole
- Edrecolomab
- Efaproxiral
- Eftilagimod alpha
- Eganelisib
- Elacestrant
- Elesclomol
- Ellagitannin
- Ellipticine
- Elotuzumab
- Elranatamab
- Elsamitrucin
- Enasidenib
- Endostatin
- Endosulfan
- Endoxifen
- Enfortumab vedotin
- Enilconazole
- Enloplatin
- Enobosarm
- Enocitabine
- Enoticumab
- Enoxacin
- Enrofloxacin
- Ensituximab
- Entolimod
- Entospletinib
- Entrectinib
- Enzalutamide
- Epacadostat
- Epcoritamab
- Epigallocatechin gallate
- Epirubicin
- Epitiostanol
- Epothilone
- Epoxomicin
- Epratuzumab
- Erbulozole
- Erdafitinib
- Eribulin
- Erlotinib
- Ertumaxomab
- Esterified estrogens
- Estetrol (medication)
- Estradiol (medication)
- Estradiol benzoate
- Estradiol dipropionate
- Estradiol mustard
- Estradiol undecylate
- Estradiol valerate
- Estramustine
- Estramustine phosphate
- Estrogen (medication)
- Estromustine
- Etacstil
- Etaracizumab
- Ethamoxytriphetol
- Ethandrostate
- Ethidium bromide
- Ethinylestradiol
- Ethinylestradiol sulfonate
- Ethionine
- Ethylcholine mustard
- Ethyldichloroarsine
- Etirinotecan pegol
- Etoglucid
- Etoposide
- Everolimus
- Evofosfamide
- Exatecan
- Exemestane
- Exisulind
- Experimental cancer drugs
- FCM (chemotherapy)
- FLAG (chemotherapy)
- FM (chemotherapy)
- FOLFIRI
- FOLFIRINOX
- FOLFOX
- FOLFOXIRI
- Fadrozole
- Famitinib
- Faricimab
- Fenarimol
- Fenretinide
- Figitumumab
- Filanesib
- Filgotinib
- Finafloxacin
- Finrozole
- Fisetin
- Fleroxacin
- Floxuridine
- Fluasterone
- Fludarabine
- Flumequine
- Fluorometholone acetate
- Fluoroquinolone antibiotics
- Fluorouracil
- Fluoxymesterone
- Flutamide
- Folinic acid
- Foretinib
- Formestane
- Forodesine
- Fosbretabulin
- Fosfestrol
- Fostamatinib
- Fotemustine
- Fruquintinib
- Fulvestrant
- Futibatinib
- Futuximab
- GTx-758
- GVAX
- GVD (chemotherapy)
- Galunisertib
- Gandotinib
- Gatifloxacin
- Gavilimomab
- Gedatolisib
- Gedunin
- Gefitinib
- GemOx
- Gemcitabine
- Gemifloxacin
- Gemtuzumab ozogamicin
- Gestonorone caproate
- Gilteritinib
- Gilvocarcin V
- Ginkgotoxin
- Glasdegib
- Glembatumumab vedotin
- Glesatinib
- Globo H
- Glofitamab
- Glucarpidase
- Glufosfamide
- Gossypetin
- Grandinin
- Grepafloxacin
- HAMLET (protein complex)
- HN1 (nitrogen mustard)
- HN3 (nitrogen mustard)
- HU-336
- HU-345
- Hesperetin
- High-dose estrogen therapy
- Hormonal therapy (oncology)
- Hydroxycarbamide
- Hyper-CVAD
- Hypomethylating agent
- ICE (chemotherapy)
- ICI-164384
- ICI-85966
- ICRF 193
- IFL (chemotherapy)
- IMEP (chemotherapy)
- IMM-101
- IRGD
- Ibafloxacin
- Iberdomide
- Ibritumomab tiuxetan
- Ibrutinib
- Icotinib
- Icrucumab
- Idarubicin
- Idelalisib
- Idoxifene
- Ieramilimab
- Ifinatamab deruxtecan
- Ifosfamide
- Imalumab
- Imatinib
- Imetelstat
- Imexon
- Imgatuzumab
- Imiquimod
- Imlunestrant
- Immunoconjugate
- Inavolisib
- Indatuximab ravtansine
- Indisulam
- Indium (111In) igovomab
- Indolocarbazole
- Inebilizumab
- Infigratinib
- Ingenol mebutate
- Inotuzumab ozogamicin
- Intetumumab
- Ipatasertib
- Ipilimumab
- Iratumumab
- Irinotecan
- Irofulven
- Irosustat
- Isatuximab
- Isoconazole
- Isoniazid
- Istiratumab
- Ivarmacitinib
- Ivosidenib
- Ixabepilone
- Ixazomib
- JNJ-Q2
- JT-010
- Jaktinib
- Janus kinase 3 inhibitor
- Janus kinase inhibitor
- KP1019
- Kairbaan Hodivala-Dilke
- Kedarcidin
- Ketoconazole
- Ketodarolutamide
- LG-2527
- LS-1727
- Labetuzumab
- Laniquidar
- Lapatinib
- Larotaxel
- Larotrectinib
- Lascufloxacin
- Lasofoxifene
- Leflutrozole
- Lenalidomide
- Leniolisib
- Lestaurtinib
- Letrozole
- Leuprorelin
- Levofloxacin
- Lewisite
- Lexatumumab
- Liarozole
- Lifastuzumab vedotin
- Lilotomab
- Linifanib
- Linoleic acid
- Linolenic acid
- Linsitinib
- Lintuzumab
- Lipoplatin
- Liposomal daunorubicin
- Liquiritigenin
- Lirilumab
- Lisocabtagene maraleucel
- Lobaplatin
- Lomefloxacin
- Lomustine
- Loncastuximab tesirine
- Lonidamine
- Lorlatinib
- Lorvotuzumab mertansine
- Losoxantrone
- Low-dose chemotherapy
- Lucanthone
- Lucatumumab
- Lucitanib
- Luminespib
- Lurbinectedin
- Lurtotecan
- Lyngbyatoxin-a
- M2613
- MDX-1097
- MG132
- MINE (chemotherapy)
- MK-2206
- MK-434
- MOPP (chemotherapy)
- MRTX1133
- MTOR inhibitors
- Mafosfamide
- Mannomustine
- Mannosulfan
- Mapatumumab
- Marbofloxacin
- Margetuximab
- Marimastat
- Masitinib
- Masoprocol
- Matuzumab
- Medroxyprogesterone acetate
- Megestrol acetate
- Melanizing agents
- Melatonin
- Melengestrol
- Melengestrol acetate
- Melphalan
- Menogaril
- Mepitiostane
- Merafloxacin
- Mercaptopurine
- Merestinib
- Mertansine
- Mesna
- Metapristone
- Metastasis suppressor
- Methotrexate
- Methoxsalen
- Methyl aminolevulinate
- Methyldichloroarsine
- Methylepitiostanol
- Methyltestosterone
- Metronomic therapy
- Miconazole
- Milatuzumab
- Miltefosine
- Minamestane
- Minretumomab
- Miproxifene
- Miproxifene phosphate
- Miriplatin
- Mirvetuximab soravtansine
- Mitobronitol
- Mitoguazone
- Mitomycin C
- Mitomycins
- Mitomycins
- Mitotane
- Mitotic inhibitor
- Mitoxantrone
- Mitumomab
- Modotuximab
- Momelotinib
- Monoclonal antibody therapy
- Monomethyl auristatin E
- Monomethyl auristatin F
- Monomethylhydrazine
- Mosunetuzumab
- Motesanib
- Moxetumomab pasudotox
- Moxifloxacin
- Mubritinib
- Mustard gas
- Myricetin
- N,N-Didesmethyltamoxifen
- N-Desmethylapalutamide
- N-Desmethylenzalutamide
- N-Desmethyltamoxifen
- N-Nitroso-N-methylurea
- NAMI-A
- NK012
- NL-201
- Nacolomab tafenatox
- Nadifloxacin
- Nafoxidine
- Nalidixic acid
- Naptumomab estafenatox
- Naringenin
- Navitoclax
- Necitumumab
- Nedaplatin
- Nelarabine
- Nemtabrutinib
- Neocarzinostatin
- Neoxaline
- Neratinib
- Nesvacumab
- Nilotinib
- Nilutamide
- Nimorazole
- Nimotuzumab
- Nimustine
- Nintedanib
- Nitrogen mustard
- Nitrogen mustards
- Nitrosoureas
- Nivolumab
- Nivolumab/relatlimab
- Nocodazole
- Nogalamycin
- Nonsteroidal antiandrogen
- Norendoxifen
- Norethisterone
- Norfloxacin
- Normustine
- Novobiocin
- O-Mustard
- O6-Benzylguanine
- ONX-0801
- OSI-7904
- OSU-03012
- Obatoclax
- Obinutuzumab
- Oblimersen
- Oclacitinib
- Ofatumumab
- Ofloxacin
- Ofranergene obadenovec
- Olaratumab
- Olmutinib
- Oltipraz
- Olutasidenib
- Olverembatinib
- Ombrabulin
- Onapristone
- Ontuxizumab
- Opnurasib
- Oportuzumab monatox
- Oprozomib
- Orbifloxacin
- Oregovomab
- Ortataxel
- Osimertinib
- Oxaliplatin
- Oxofluoxymesterone
- Ozarelix
- Ozogamicin
- PAC-1
- PR-104
- Paclitaxel
- Paclitaxel trevatide
- Pacritinib
- Padeliporfin
- Palau'amine
- Palmitic acid
- Palytoxin
- Panitumumab
- Panomifene
- Parsatuzumab
- Patritumab
- Patritumab deruxtecan
- Pazopanib
- Pazufloxacin
- Pederin
- Peficitinib
- Pefloxacin
- Pegaptanib
- Pegaspargase
- Pegdinetanib
- Pelareorep
- Pembrolizumab
- Pemetrexed
- Pemigatinib
- Pemtumomab
- Pentostatin
- Perfosfamide
- Pertuzumab
- Pevonedistat
- Phenanthriplatin
- Phenestrol
- Phenoxybenzamine
- Phenyldichloroarsine
- Phenytoin
- Photosensitizing agents
- Picibanil
- Picoplatin
- Pimitespib
- Pinatuzumab vedotin
- Pingyangmycin
- Pinocembrin
- Pipendoxifene
- Pipobroman
- Pirarubicin
- Pirtobrutinib
- Pixantrone
- Plicamycin
- Plinabulin
- Plitidepsin
- Plomestane
- Polatuzumab vedotin
- Polmacoxib
- Polyestradiol phosphate
- Polymer-drug conjugates
- Ponatinib
- Ponsegromab
- Porfimer sodium
- Porfiromycin
- Poziotinib
- Pradofloxacin
- Pralatrexate
- Pralsetinib
- Prednimustine
- Prexasertib
- Prinomastat
- Pritumumab
- Procarbazine
- Prochloraz
- Propiconazole
- Prostaglandin E2
- Proteasome inhibitor
- Protein-bound paclitaxel
- Proxalutamide
- Prulifloxacin
- Psoralen
- Purine analogue
- Pyrimidine analogue
- Quadrosilan
- Quercetin
- Quisinostat
- Quizartinib
- R-CHOP
- R-HDAC
- RAPTA
- RD-162
- RO4929097
- Radium-223
- Radotinib
- Radretumab
- Ralimetinib
- Raltitrexed
- Ramucirumab
- Ranibizumab
- Ranimustine
- Rasburicase
- Rebeccamycin
- Regorafenib
- Relatlimab
- Relugolix
- Remibrutinib
- Rencofilstat
- Repotrectinib
- Resimmune
- Resiquimod
- Resveratrol
- Retifanlimab
- Rezvilutamide
- Rigosertib
- Rindopepimut
- Ripretinib
- Ritlecitinib
- Rituximab
- Robatumumab
- Rociletinib
- Rogletimide
- Romidepsin
- Rotenone
- Rovalpituzumab tesirine
- Rubitecan
- Rufloxacin
- Ruthenium anti-cancer drugs
- Ruxolitinib
- SN-38
- Sabarubicin
- Sabizabulin
- Sacituzumab govitecan
- Sakuranetin
- Salinosporamide A
- Sapacitabine
- Sapanisertib
- Saracatinib
- Sarafloxacin
- Saridegib
- Satraplatin
- Savolitinib
- Selinexor
- Selpercatinib
- Selumetinib
- Selvigaltin
- Semaxanib
- Semustine
- Seribantumab
- Sesquimustard
- Seviteronel
- Sibrotuzumab
- Sintilimab
- Sitafloxacin
- Sitravatinib
- Sivifene
- Sofituzumab vedotin
- Solitomab
- Sonidegib
- Sorafenib
- Sotorasib
- Sparfloxacin
- Sparsomycin
- Spindle poison
- Squalamine
- Src inhibitor
- Stanford V
- Steganacin
- Steroidal antiandrogen
- Streptozotocin
- Sturamustine
- Sulforaphane
- Sunitinib
- Swainsonine
- T-2 mycotoxin
- T790M
- TAS-108
- TCH (chemotherapy)
- TL-301
- TNP-470
- Talaporfin
- Talazoparib
- Talimogene laherparepvec
- Talquetamab
- Tamibarotene
- Tamoxifen
- Tanespimycin
- Taplitumomab paptox
- Tarextumab
- Targeted therapy
- Tariquidar
- Tarlatamab
- Tasquinimod
- Taxane
- Taxoid
- Tazemetostat
- Tebentafusp
- Technetium (99mTc) pintumomab
- Technetium (99mTc) sulesomab
- Technetium (99mTc) votumumab
- Techtochrysin
- Teclistamab
- Tegafur
- Tegafur/gimeracil/oteracil
- Tegafur/uracil
- Temafloxacin
- Temoporfin
- Temozolomide
- Temsirolimus
- Teniposide
- Tepotinib
- Teprotumumab
- Tesetaxel
- Tesevatinib
- Tesmilifene
- Testifenon
- Testolactone
- Testosterone (medication)
- Tetrahydrocannabinol
- Thiotepa
- Tiazofurin
- Tigilanol tiglate
- Tilomisole
- Tioconazole
- Tioguanine
- Tirapazamine
- Tisagenlecleucel
- Tisotumab vedotin
- Tissue-agnostic cancer drug
- Tivantinib
- Tivozanib
- Toceranib
- Tofacitinib
- Topoisomerase inhibitor
- Topotecan
- Toremifene
- Toripalimab
- Tosufloxacin
- Tovetumab
- Toxopyrimidine
- Trabectedin
- Trastuzumab
- Trastuzumab deruxtecan
- Trastuzumab emtansine
- Trastuzumab/hyaluronidase
- Treosulfan
- Tretinoin
- Triadimefon
- Triaziquone
- Triciribine
- Triethylenemelamine
- Trifluridine
- Trifluridine/tipiracil
- Trilaciclib
- Trimethoprim
- Trimetrexate
- Triphenylchloroethylene
- Triphenylmethylethylene
- Triplatin tetranitrate
- Trofosfamide
- Troglitazone
- Tropoflavin
- Trovafloxacin
- Troxacitabine
- Tucatinib
- Tucotuzumab celmoleukin
- Tumstatin
- Tyrosine kinase inhibitor
- Tyrosine kinase inhibitors
- Ubenimex
- Upadacitinib
- Upamostat
- Uramustine
- Urelumab
- V600E
- VAMP regimen
- VEGFR-2 inhibitor
- Vadastuximab talirine
- Vadimezan
- Valproate
- Valrubicin
- Valspodar
- Vandetanib
- Vandortuzumab vedotin
- Vantictumab
- Vanucizumab
- Vapreotide
- Vatalanib
- Veliparib
- Venetoclax
- Vepdegestrant
- Vernolepin
- Verteporfin
- Vinblastine
- Vinca alkaloid
- Vincristine
- Vindesine
- Vinflunine
- Vinorelbine
- Vintafolide
- Vismodegib
- Vitamin K antagonist
- Vitaxin
- Volasertib
- Volociximab
- Vorasidenib
- Vorinostat
- Vorozole
- Vorsetuzumab mafodotin
- Vosaroxin
- Vosilasarm
- Voxtalisib
- XL-413
- ZB716
- ZGN-1061
- Zabofloxacin
- Zalutumumab
- Zanzalintinib
- Zearalenone
- Zibotentan
- Zindoxifene
- Zolbetuximab
- Zoptarelin doxorubicin
- Zorubicin
- Zosuquidar
- Α-Amanitin
- Α-Naphthoflavone
- Δ4-Abiraterone
External links[edit]
Comprehensive list of cancer drugs from the National Cancer Institute at the National Institutes of Health.
Drugs Approved for Different Types of Cancer[edit]
This page lists and links to NCI's pages of drugs approved for specific types of cancer.
Drugs Approved for Conditions Related to Cancer[edit]
People with cancer may have conditions caused by the cancer or its treatment. Find drugs approved for some of these cancer-related conditions.
A | B | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
| Overview of tumors, cancer and oncology (C00–D48, 140–239) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
See Also[edit]